Toledo-Pereyra L H, Bandlien K O, Gordon D A, MacKenzie G H, Reyman T A
Diabetes. 1984 Sep;33(9):910-4. doi: 10.2337/diab.33.9.910.
Islet cell transplantation has been associated with ultimate graft rejection. This preliminary study investigates the use of the renal subcapsular region as a site for placement of canine islet cell allografts. A new noncollagenase mechanical technique was used for preparation of the allografts. Animals in group I (N = 6) died of hyperglycemia in 4.0 +/- 1.89 days (X +/- SD) after pancreatectomy without subsequent islet cell transplant. Normoglycemia and excellent survival (greater than 60 days) was obtained in pancreatectomized animals in group II (N = 6) and in group III (N = 6), who received an islet cell allograft to the renal subcapsular site. Group II recipients were given no immunosuppression, and animals in group III received minimal immunosuppression with azathioprine. Dependence on the islet cell allograft for maintenance of normoglycemia was confirmed in the majority of the recipients by nephrectomy, to remove the graft, with resulting hyperglycemia and death. One normoglycemic animal in group II died on day 6 from peritonitis. One recipient in group II was normoglycemic at greater than 1 mo after removal of the first graft by nephrectomy, followed by retransplantation of islet cells from a third-party donor. Two other recipients are being studied on a long-term basis, and have been normoglycemic for greater than 6 mo and greater than 4 mo after transplantation. These studies encourage further investigation in this area for application of islet cell transplantation in man, and elucidation of the possible mechanisms for prolongation of islet cell allograft survival at the renal subcapsular site.
胰岛细胞移植一直与最终的移植物排斥反应相关。这项初步研究调查了将肾被膜下区域作为犬胰岛细胞同种异体移植物植入部位的应用情况。一种新的非胶原酶机械技术被用于制备同种异体移植物。第一组(N = 6)的动物在胰腺切除术后未进行后续胰岛细胞移植,于4.0 +/- 1.89天(X +/- SD)死于高血糖症。在接受了肾被膜下部位胰岛细胞同种异体移植的第二组(N = 6)和第三组(N = 6)的胰腺切除动物中,实现了血糖正常和良好的存活(超过60天)。第二组受体未接受免疫抑制,第三组动物接受了硫唑嘌呤的最小免疫抑制。通过肾切除术移除移植物后导致高血糖症和死亡,从而在大多数受体中证实了对胰岛细胞同种异体移植物维持血糖正常的依赖性。第二组中有一只血糖正常的动物在第6天死于腹膜炎。第二组中有一名受体在通过肾切除术移除第一个移植物后1个月以上血糖正常,随后接受了来自第三方供体的胰岛细胞再移植。另外两名受体正在进行长期研究,移植后分别已血糖正常超过6个月和超过4个月。这些研究鼓励在该领域进一步开展研究,以便将胰岛细胞移植应用于人类,并阐明在肾被膜下部位延长胰岛细胞同种异体移植物存活的可能机制。